| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |